Kathryn Todd, Ph.D.

Dr. Todd obtained her Ph.D. at the University of Alberta.  Research in the Todd group is primarily related to cellular mechanisms involved in neurodegenerative and neuropschiatric disorders and the identification of neuroprotective and/or rescue agents.  In addition to her position at the University of Alberta, she is currently the Senior Vice President of Research at Alberta Health Services.  Research in the Todd group is instrumental in understanding the biocompatibility of intraspinal electrode implants.  More specifically, the Todd group is investigating the immunological and neurologic cellular response to electrode implantation and investigating strategies to minimize inflammation and other adverse immune responses that lead to bio-incompatibility.